Author:
McCombie Stuart W.,Tagat Jayaram R.,Vice Susan F.,Lin Sue-Ing,Steensma Ruo,Palani Anandan,Neustadt Bernard R.,Baroudy Bahige M.,Strizki Julie M.,Endres Michael,Cox Kathleen,Dan Niya,Chou Chuan-Chu
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference19 articles.
1. McCombie, S.; Vice, S.; Tagat, J.; Lin, S.-I.; Palani, A.; Neustadt, B.; Baroudy, B.; Strizki, J.; Endres, M.; Cox, K.; Dan, N.; Chou, C.-C. Abstracts of Papers, 223rd ACS National Meeting, Orlando, FL, April 7–11, 2002; American Chemical Society: Washington, DC, 2002; MEDI 159.
2. Discovery of Novel, Potent, and Selective Small-Molecule CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Evaluation of Anilide Derivatives with a Quaternary Ammonium Moiety
3. CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines
4. Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5
5. Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献